Clinical and Serological Characteristics of Ocular Toxoplasmosis in the Democratic Republic of Congo

References

• Weiss LM, Dubey JP. Toxoplasmosis: a history of clinical observations. Int J Parasitol. 2009 Jul 1;39(8):895–901. doi:10.1016/j.ijpara.2009.02.004.
   PubMed Web of Science ®Google Scholar
• Maenz M, Schlüter D, Liesenfeld O, Schares G, Gross U, Pleyer U. Ocular toxoplasmosis past, present and new aspects of an old disease. Prog Retin Eye Res. Mar 2014;39:77–106. doi:10.1016/j.preteyeres.2013.12.005.
   PubMed Web of Science ®Google Scholar
• Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009 Oct;39(12):1385–1394. doi:10.1016/j.ijpara.2009.04.003.
   PubMed Web of Science ®Google Scholar
• Hammond-Aryee K, Esser M, Van Helden P. Toxoplasma gondii seroprevalence studies on humans and animals in Africa. South Afr Fam Pract. 2014 Mar 1;56(2):119–124. doi:10.1080/20786204.2014.10855349.
   Google Scholar
• Alsammani MA. Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries. J Parasit Dis Off Organ Indian Soc Parasitol. 2016 Sep;40(3):569–579. doi:10.1007/s12639-014-0558-8.
   PubMedGoogle Scholar
• Doudou Y, Renaud P, Coralie L, et al. Toxoplasmosis among pregnant women: high seroprevalence and risk factors in Kinshasa, Democratic Republic of Congo. Asian Pac J Trop Biomed. 2014 Jan;4(1):69–74. doi:10.1016/S2221-1691(14)60211-2.
   PubMedGoogle Scholar
• Brezin AP, Guillevin L, Société française d’ophtalmologie. Uvéites [rapport présenté à la] Société Française d’Ophtalmologie. Issy-les-Moulineaux: Elsevier-Masson; 2010.
   Google Scholar
• Pleyer U, Schlüter D, Mänz M. Ocular toxoplasmosis: recent aspects of pathophysiology and clinical implications. Ophthal Res. 2014;52(3):116–123. doi:10.1159/000363141.
   PubMed Web of Science ®Google Scholar
• Shobab L, Pleyer U, Johnsen J, et al. Toxoplasma serotype is associated with development of ocular toxoplasmosis. J Infect Dis. 2013 Nov 1;208(9):1520–1528. doi:10.1093/infdis/jit313.
   PubMed Web of Science ®Google Scholar
• Ronday MJ, Stilma JS, Barbe RF, et al. Aetiology of uveitis in Sierra Leone, West Africa. Br J Ophthalmol. 1996 Nov;80(11):956–961. doi:10.1136/bjo.80.11.956.
   PubMed Web of Science ®Google Scholar
• Koffi KV, Kouassi FX, Kouassi AC, Effi H, Safede K, Keita CT. Les uvéites : profils épidémiologique, clinique et thérapeutique au CHU Cocody (Abidjan - Côte d’Ivoire). Méd Afr Noire. 2001;48(2):67–72. http://www.santetropicale.com/Resume/24805.pdf.
   Google Scholar
• Chebil A, Baroudi B, Slim M, et al. Profil épidémiologique des uvéites dans la région de Tunis. J Fr Ophtalmol. 2013 Nov;36(9):764–768. doi:10.1016/j.jfo.2013.05.006.
   PubMedGoogle Scholar
• Khairallah M. Etiologies des uveites posterieures et des panuveites au centre hospitalo-universitaire de Monastir, tunisie.[Internet]. https://docplayer.fr/51544590-Etiologies-des-uveites-posterieures-et-des-panuveites-au-centre-hospitalo-universitaire-de-monastir-tunisie.html. Accessed Oct 15, 2019.
   Google Scholar
• Gilbert RE, Freeman K, Lago EG, et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008 Aug 13;2(8):e277. doi:10.1371/journal.pntd.0000277.
   PubMed Web of Science ®Google Scholar
• Pfaff AW, de-la-Torre A, Rochet E, et al. New clinical and experimental insights into Old World and neotropical ocular toxoplasmosis. Int J Parasitol. 2014 Feb;44(2):99–107. doi:10.1016/j.ijpara.2013.09.007.
   PubMed Web of Science ®Google Scholar
• Sauer A, de la Torre A, Gomez-Marin J, et al. Prevention of retinochoroiditis in congenital toxoplasmosis: Europe versus South America. Pediatr Infect Dis J. 2011 Jul;30(7):601–603. doi:10.1097/INF.0b013e3182129e70.
   PubMed Web of Science ®Google Scholar
• Holland GN. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol. Jan 1, 2004;137(1):1–17.
   PubMed Web of Science ®Google Scholar
• Hung CC, Fan CK, Su KE, et al. Serological screening and toxoplasmosis exposure factors among pregnant women in the Democratic Republic of Sao Tome and Principe. Trans R Soc Trop Med Hyg. 2007 Feb;101(2):134–139. doi:10.1016/j.trstmh.2006.04.012.
   PubMed Web of Science ®Google Scholar
• Swai ES, Schoonman L. Seroprevalence of Toxoplasma gondii infection amongst residents of Tanga district in north-east Tanzania. Tanzan J Health Res. 2009 Oct;11(4):205–209. doi:10.4314/thrb.v11i4.50178.
   PubMedGoogle Scholar
• World Health Organization − International Statistical Classification of Diseases and Related Health Problems. 10th revision. Current version. Version for 2003. Chapter VII. H54. Blindness and low vision.
   Google Scholar
• Aleixo ALQDC, Curi ALL, Benchimol EI, Amendoeira MRR. Toxoplasmic retinochoroiditis: clinical characteristics and visual outcome in a prospective study. PLoS Negl Trop Dis. 2016 May;10(5):e0004685. doi:10.1371/journal.pntd.0004685.
   PubMed Web of Science ®Google Scholar
• de-la-Torre A, López-Castillo CA, Gómez-Marín JE. Incidence and clinical characteristics in a Colombian cohort of ocular toxoplasmosis. Eye (Lond Engl). 2009 May;23(5):1090–1093. doi:10.1038/eye.2008.219.
   PubMed Web of Science ®Google Scholar
• Schlaen A, Colombero D, Ormaechea S, et al. Regional differences in the clinical manifestation of ocular toxoplasmosis between the center and northeast of Argentina. Ocul Immunol Inflamm. 2019;27(5):722–730. doi:10.1080/09273948.2018.1484494.
   PubMed Web of Science ®Google Scholar
• Abu EK, Boampong JN, Amoabeng JK, et al. Epidemiology of ocular toxoplasmosis in three community surveys in the Central Region of Ghana, West Africa. Ophthalmic Epidemiol. 2016;23(1):14–19. doi:10.3109/09286586.2015.1089579.
   PubMed Web of Science ®Google Scholar
• Abraham EG, Moses AE, Motilewa USOO, Uwah AI, Itina EI, Umoh AN. Ocular toxoplasmosis among livestock farmers and raw meat handlers in Uyo, Nigeria. Ethiop J Health Sci. 2021 Mar;31(2):257–266. doi:10.4314/ejhs.v31i2.8.
   PubMed Web of Science ®Google Scholar
• Nsiangani Lusambo N, Kaimbo Wa Kaimbo D. Epidemiology and clinical pattern of ocular toxoplasmosis in Kinshasa. J Fr Ophtalmol. 2019 Oct;42(8):900–906. doi:10.1016/j.jfo.2019.05.017.
   PubMed Web of Science ®Google Scholar
• Butler NJ, Furtado JM, Winthrop KL, Smith JR. Ocular toxoplasmosis II: clinical features, pathology and management. Clin Exp Ophthalmol. 2013 Feb;41(1):95–108. doi:10.1111/j.1442-9071.2012.02838.x.
   PubMed Web of Science ®Google Scholar
• Bosch-Driessen LEH, Berendschot TTJM, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology. 2002 May;109(5):869–878. doi:10.1016/S0161-6420(02)00990-9.
   PubMed Web of Science ®Google Scholar
• Bustillo JL, Diaz JD, Pacheco IC, Gritz DC. Cuban Ocular Toxoplasmosis Epidemiology Study (COTES): incidence and prevalence of ocular toxoplasmosis in Central Cuba. Br J Ophthalmol. 2015 Mar;99(3):382–386. doi:10.1136/bjophthalmol-2014-305843.
   PubMed Web of Science ®Google Scholar
• Huang PK, Jianping C, Vasconcelos-Santos DV, et al. Ocular toxoplasmosis in tropical areas: analysis and outcome of 190 patients from a multicenter collaborative study. Ocul Immunol Inflamm. 2018;26(8):1289–1296. doi:10.1080/09273948.2017.1367407.
   PubMed Web of Science ®Google Scholar
• Balasundaram MB, Andavar R, Palaniswamy M, Venkatapathy N. Outbreak of acquired ocular toxoplasmosis involving 248 patients. Arch Ophthalmol Chic IL 1960 Internet]. 2010 Jan; 128(1). https://pubmed.ncbi.nlm.nih.gov/20065213/. [Accessed Jul 14, 2021.
   Google Scholar
• Tugal-Tutkun I, Corum I, Otük B, Urgancioglu M. Active ocular toxoplasmosis in Turkish patients: a report on 109 cases. Int Ophthalmol. 2005 Dec;26(6):221–228. doi:10.1007/s10792-007-9047-8.
   PubMedGoogle Scholar
• Vishnevskia-Dai V, Achiron A, Buhbut O, et al. Chorio-retinal toxoplasmosis: treatment outcomes, lesion evolution and long-term follow-up in a single tertiary center. Int Ophthalmol. 2020 Apr;40(4):811–821. doi:10.1007/s10792-019-01242-1.
   PubMed Web of Science ®Google Scholar
• Yates WB, Chiong F, Zagora S, Post JJ, Wakefield D, McCluskey P. Ocular toxoplasmosis in a tertiary referral center in Sydney Australia-clinical features, treatment, and prognosis. Asia-Pac J Ophthalmol Phila Pa. 2019 Aug;8(4):280–284. doi:10.1097/APO.0000000000000244.
   PubMed Web of Science ®Google Scholar
• Arruda S, Vieira BR, Garcia DM, et al. Clinical manifestations and visual outcomes associated with ocular toxoplasmosis in a Brazilian population. Sci Rep. 2021 Feb 4;11(1):3137. doi:10.1038/s41598-021-82830-z.
   PubMed Web of Science ®Google Scholar
• Jones JL, Muccioli C, Belfort R, Holland GN, Roberts JM, Silveira C. Recently acquired Toxoplasma gondii infection, Brazil. Emerg Infect Dis. 2006 Apr;12(4):582–587. doi:10.3201/eid1204.051081.
   PubMed Web of Science ®Google Scholar
• Te A, Silveira C, Gn H, et al. Ocular involvement following postnatally acquired toxoplasma gondii infection in Southern Brazil: a 28-year experience [Internet]. Am J Ophthalmol. 2015Jun;159(6): Accessed Feb 6, 2022. https://pubmed.ncbi.nlm.nih.gov/25743338/
   Web of Science ®Google Scholar
• Holland GN. Ocular toxoplasmosis: the influence of patient age. Mem Inst Oswaldo Cruz. 2009 Mar;104(2):351–357. doi:10.1590/S0074-02762009000200031.
   PubMed Web of Science ®Google Scholar
• Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol. 2003 Dec;136(6):973–988. doi:10.1016/j.ajo.2003.09.040.
   PubMed Web of Science ®Google Scholar
• Rahimi-Esboei B, Zarei M, Mohebali M, et al. Serologic tests of IgG and IgM antibodies and IgG avidity for diagnosis of ocular toxoplasmosis. Korean J Parasitol. 2018 Apr;56(2):147–152. doi:10.3347/kjp.2018.56.2.147.
   PubMed Web of Science ®Google Scholar
• Ozgonul C, Besirli CG. Recent developments in the diagnosis and treatment of ocular toxoplasmosis. Ophthalmic Res. 2017;57(1):1–12. doi:10.1159/000449169.
   PubMed Web of Science ®Google Scholar
• Hosseini SM, Moghaddas E, Sharifi K, Dadgar Moghaddam M, Shamsian SA. Assessment of ocular toxoplasmosis patients reported at a tertiary center in the northeast of Iran. Int Ophthalmol. 2018 Dec 1;38(6):2527–2533. doi:10.1007/s10792-017-0764-3.
   PubMed Web of Science ®Google Scholar
• Bhikoo R, Damato EM, Guest S, Sims J. Primary ocular toxoplasmosis presenting to uveitis services in a non-endemic setting. Korean J Ophthalmol. 2019 Dec;33(6):514–519. doi:10.3341/kjo.2019.0092.
   PubMedGoogle Scholar
• Westfall AC, Lauer AK, Suhler EB, Rosenbaum JT. Toxoplasmosis retinochoroiditis and elevated intraocular pressure: a retrospective study. J Glaucoma. 2005 Feb;14(1):3–10. doi:10.1097/01.ijg.0000146373.51495.c1.
   PubMed Web of Science ®Google Scholar
• Greigert V, Di Foggia E, Filisetti D, et al. When biology supports clinical diagnosis: review of techniques to diagnose ocular toxoplasmosis [Internet]. Br J Ophthalmol. 2019;103(7):1008–1012. https://bjo.bmj.com/content/103/7/1008.abstract. Accessed Oct 14, 2019.
   PubMed Web of Science ®Google Scholar
• Samudio M, Acosta ME, Castillo V, et al. Aspectos clínico-epidemiológicos de la toxoplasmosis en pacientes que consultan por problemas de visión. Rev Chil Infectol. 2015;32(6):658–663. doi:10.4067/S0716-10182015000700007.
   PubMedGoogle Scholar
• Ongkosuwito OJ, Bosch-Driessen EH, Kihlstra A, Rothova A. Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection. PubMed - NCBI [Internet]. https://www.ncbi.nlm.nih.gov/pubmed/10577580. Accessed Oct 16, 2019.
   Google Scholar
• Ajamil-Rodanes S, Luis J, Bourkiza R, et al. Ocular toxoplasmosis: phenotype differences between toxoplasma IgM positive and IgM negative patients in a large cohort. Br J Ophthalmol. 2020 Apr 28;105: bjophthalmol–2019.
   PubMed Web of Science ®Google Scholar